Orthocell Ltd has released a press release.
Leading US-based nerve surgeons appointed to advisory board
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Orthocell
- Half Yearly Report and Accounts
- Appendix 4C - Quarterly
- Remplir Gains Australian Reimbursement
- OrthoATI Rotator Cuff Study Success With Cross-Over Patients
- First orders for Striate and Remplir
Later from Orthocell
- Orthocell commences nerve repair study
- Orthocell receives A$3.17m R&D tax incentive refund
- Striate re-certified under new European medical device regs
- UWA Royalty Entitlement Exchanged for Shares in Orthocell
- Successful OrthoATI clinical trial
Follow Orthocell into a list and get an email when it puts out news.
Follow Orthocell